Heron

APONVIE

Manufacturer:

Heron

Aponvie HCPCS:

C9145

HCPCS Code Descriptor:

Injection, aprepitant, (aponvie), 1 mg

Category:

C Code

Aponvie NDCs:

47426-0401-10

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

47426-0401-10

About Aponvie:

APONVIE is an Oncology-Anti-Emetic drug manufactured by Heron and administered via the Intravenous route of administration. The C Code: C9145 is aligned to the drug APONVIE.

ACCESS PRICING AND MORE BY REGISTERING

C9145 Added Date:

April 1, 2023

C9145 Effective Date:

April 1, 2023

C9145 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Aponvie billing and coding information.
Aponvie patient assistance information can be found through Heron Connect at the URL: https://www.heronconnect.com/APONVIE/Overview
APONVIE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for APONVIE. Please check back in a few weeks.